Search Results - "Russell, W Alton"

Refine Results
  1. 1

    Estimating the Effect of Discontinuing Universal Screening of Donated Blood for Zika Virus in the 50 U.S. States by Russell, W Alton

    Published in Annals of internal medicine (01-05-2021)
    “…Most Zika infections are asymptomatic, but about 20% of infected persons develop mild febrile illness. Rarely, Zika can cause 2 serious complications:…”
    Get full text
    Journal Article
  2. 2

    Individualized risk trajectories for iron‐related adverse outcomes in repeat blood donors by Russell, W. Alton, Scheinker, David, Custer, Brian

    Published in Transfusion (Philadelphia, Pa.) (01-01-2022)
    “…Background Despite a fingerstick hemoglobin requirement and 56‐day minimum donation interval, repeat blood donation continues to cause and exacerbate iron…”
    Get full text
    Journal Article
  3. 3

    Factors driving availability of COVID‐19 convalescent plasma: Insights from a demand, production, and supply model by Russell, W. Alton, Grebe, Eduard, Custer, Brian

    Published in Transfusion (Philadelphia, Pa.) (01-05-2021)
    “…Background COVID‐19 Convalescent Plasma (CCP) is a promising treatment for COVID‐19. Blood collectors have rapidly scaled up collection and distribution…”
    Get full text
    Journal Article
  4. 4

    Screening the Blood Supply for Zika Virus in the 50 U.S. States and Puerto Rico: A Cost-Effectiveness Analysis by Russell, W Alton, Stramer, Susan L, Busch, Michael P, Custer, Brian

    Published in Annals of internal medicine (05-02-2019)
    “…In 2016, universal individual donation nucleic acid testing (ID-NAT) of donated blood for Zika virus began in U.S. states and territories. To assess the…”
    Get full text
    Journal Article
  5. 5

    Baseline creatinine determination method impacts association between acute kidney injury and clinical outcomes by Russell, W. Alton, Scheinker, David, Sutherland, Scott M.

    Published in Pediatric nephrology (Berlin, West) (01-05-2021)
    “…Background Current consensus definition for acute kidney injury (AKI) does not specify how baseline serum creatinine should be determined. We assessed how…”
    Get full text
    Journal Article
  6. 6

    Blood donor return behavior in South Africa and the United States before and during the COVID‐19 pandemic by Jagirdar, Huzbah, Nwobi, Nkasiobi H., Swanevelder, Ronel, Cockeran, Riana, Bruhn, Roberta, Kaidarova, Zhanna, Bravo, Marjorie D., Berg, Karin, Custer, Brian S., Vassallo, Ralph, Ding, Yichuan, Panagiotoglou, Dimitra, Russell, W. Alton

    Published in Transfusion (Philadelphia, Pa.) (01-08-2024)
    “…Background Studies preceding the COVID‐19 pandemic found that slower time‐to‐return was associated with first‐time, deferred, and mobile drive blood donors…”
    Get full text
    Journal Article
  7. 7

    Cost‐effectiveness and budget impact of whole blood pathogen reduction in Ghana by Russell, W. Alton, Owusu‐Ofori, Shirley, Owusu‐Ofori, Alex, Micah, Eileen, Norman, Betty, Custer, Brian

    Published in Transfusion (Philadelphia, Pa.) (01-12-2021)
    “…Background Despite the promise of pathogen reduction for reducing transfusion‐associated adverse events in sub‐Saharan Africa, no health‐economic assessment is…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Optimal portfolios of blood safety interventions: test, defer or modify? by Russell, W. Alton, Custer, Brian, Brandeau, Margaret L.

    Published in Health care management science (01-09-2021)
    “…A safe supply of blood for transfusion is a critical component of the healthcare system in all countries. Most health systems manage the risk of…”
    Get full text
    Journal Article
  10. 10

    Economic evaluation of the effect of needle and syringe programs on skin, soft tissue, and vascular infections in people who inject drugs: a microsimulation modelling approach by Lim, Jihoon, El-Sheikh, Mariam, Buckeridge, David L, Panagiotoglou, Dimitra

    Published in Harm reduction journal (28-06-2024)
    “…Needle and syringe programs (NSP) are effective harm-reduction strategies against HIV and hepatitis C. Although skin, soft tissue, and vascular infections…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Factors Associated With Abrupt Discontinuation of Long-Term High-Dose Opioid Treatment by Vivas-Valencia, Carolina, Dong, Huiru, Stringfellow, Erin J, Russell, W Alton, Morgan, Jake R, Tadrous, Mina, Jalali, Mohammad S

    Published in JAMA network open (01-11-2023)
    “…This cohort study investigates factors associated with abrupt discontinuation of long-term high-dose opioid treatment at the national level and across US…”
    Get full text
    Journal Article
  13. 13

    Cost-effectiveness of Increasing Buprenorphine Treatment Initiation, Duration, and Capacity Among Individuals Who Use Opioids by Claypool, Anneke L, DiGennaro, Catherine, Russell, W Alton, Yildirim, Melike F, Zhang, Alan F, Reid, Zuri, Stringfellow, Erin J, Bearnot, Benjamin, Schackman, Bruce R, Humphreys, Keith, Jalali, Mohammad S

    Published in JAMA health forum (05-05-2023)
    “…Buprenorphine is an effective and cost-effective medication to treat opioid use disorder (OUD), but is not readily available to many people with OUD in the US…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Temporal trends in disparities in COVID-19 seropositivity among Canadian blood donors by Yu, Yuan, Knight, Matthew J, Gibson, Diana, O'Brien, Sheila F, Buckeridge, David L, Russell, W Alton

    Published in International journal of epidemiology (05-06-2024)
    “…In Canada's largest COVID-19 serological study, SARS-CoV-2 antibodies in blood donors have been monitored since 2020. No study has analysed changes in the…”
    Get full text
    Journal Article
  16. 16

    Cost Effectiveness of Endoscopic Resection vs Transanal Resection of Complex Benign Rectal Polyps by Yu, Jessica X., Russell, W. Alton, Ching, Jack H., Kim, Nathan, Bendavid, Eran, Owens, Douglas K., Kaltenbach, Tonya

    Published in Clinical gastroenterology and hepatology (01-12-2019)
    “…Complex benign rectal polyps can be managed with transanal surgery or with endoscopic resection (ER). Though the complication rate after ER is lower than…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Clipping Over the Scope for Recurrent Peptic Ulcer Bleeding is Cost-Effective as Compared to Standard Therapy: An Initial Assessment by Yu, Jessica X, Russell, W Alton, Asokkumar, Ravishankar, Kaltenbach, Tonya, Soetikno, Roy

    “…Clipping over the scope (C-OTS) is a novel closure technique used for the treatment of nonvariceal gastrointestinal bleeding, especially for high-risk lesions…”
    Get full text
    Journal Article
  19. 19
  20. 20